Insiders the biggest winners as Silence Therapeutics plc's (NASDAQ:SLN) market cap rises to US$736m
Key Insights Significant insider control over Silence Therapeutics implies vested interests in company growth 53% of the business is held by the top 4 shareholders Institutions own 24% of Silence The...